Related Experiment Video

Updated: Jun 11, 2026

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model
09:00

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model

Published on: April 17, 2026

Protein-protein interaction antagonists as novel inhibitors of non-canonical polyubiquitylation

Johanna Scheper1, Marta Guerra-Rebollo, Glòria Sanclimens

  • 1Department of Cell Biology, Institute for Molecular Biology (IBMB-CSIC), Barcelona, Spain.

Plos One
|July 9, 2010
PubMed
Abstract

Insights

Researchers developed small molecules that inhibit Ubc13-Uev1, a key enzyme in cell stress pathways. These compounds target non-canonical polyubiquitylation, showing potential for cancer therapy by sensitizing tumor cells and inhibiting cancer growth.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Cellular stress responses involve pathways like DNA repair and NF-kappaB activation.
  • These pathways are regulated by lysine 63-based polyubiquitylation, catalyzed by Ubc13-Uev.

Purpose of the Study:

  • To develop small molecules that inhibit the Ubc13-Uev enzyme.
  • To investigate the therapeutic potential of inhibiting non-canonical polyubiquitylation in cancer.

Main Methods:

  • In vivo protein-protein interaction assays and virtual screening to identify inhibitors.
  • Assays in mammalian cells to assess inhibition of polyubiquitylation, NF-kappaB activation, and chemosensitization.
  • Inhibition of prostate cancer cell invasiveness, clonogenicity, and tumor growth.

Main Results:

  • Developed small molecules that antagonize Ubc13-Uev protein-protein interaction and inhibit its enzymatic activity.
  • Inhibition of lysine 63-type polyubiquitylation of PCNA and NF-kappaB activation by TNF-alpha in mammalian cells.
  • Demonstrated sensitization of tumor cells to chemotherapy and significant inhibition of prostate cancer progression in vivo.

Conclusions:

  • First development of pharmacological inhibitors for non-canonical polyubiquitylation.
  • Compounds show selective biological effects with potential therapeutic applications in cancer treatment.

More Related Videos

Detection of Protein Ubiquitination09:00

Detection of Protein Ubiquitination

Published on: August 19, 2009

Ubiquitin Chain Analysis by Parallel Reaction Monitoring08:33

Ubiquitin Chain Analysis by Parallel Reaction Monitoring

Published on: June 17, 2020

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...